Bank of New York Mellon
BLFS icon

Bank of New York Mellon’s BioLife Solutions BLFS Stock Holding History

Bank of New York Mellon’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.47M Buy
229,109
+17,799
+8% +$416K ﹤0.01% 2286
2026
Q1 		$4.03M Sell
211,310
-4,973
-2% -$110K ﹤0.01% 2439
2025
Q4 		$5.23M Sell
216,283
-4,562
-2% -$119K ﹤0.01% 2302
2025
Q3 		$5.63M Sell
220,845
-3,771
-2% -$89.5K ﹤0.01% 2246
2025
Q2 		$4.84M Buy
224,616
+2,827
+1% +$63.7K ﹤0.01% 2280
2025
Q1 		$5.07M Sell
221,789
-8,820
-4% -$232K ﹤0.01% 2211
2024
Q4 		$5.99M Sell
230,609
-4,612
-2% -$115K ﹤0.01% 2200
2024
Q3 		$5.89M Sell
235,221
-40,349
-15% -$953K ﹤0.01% 2216
2024
Q2 		$5.91M Buy
275,570
+8,216
+3% +$159K ﹤0.01% 2247
2024
Q1 		$4.96M Sell
267,354
-3,257
-1% -$57K ﹤0.01% 2334
2023
Q4 		$4.4M Sell
270,611
-4,690
-2% -$59.8K ﹤0.01% 2436
2023
Q3 		$3.8M Sell
275,301
-25,180
-8% -$397K ﹤0.01% 2459
2023
Q2 		$6.64M Sell
300,481
-5,759
-2% -$121K ﹤0.01% 2163
2023
Q1 		$6.66M Sell
306,240
-11,025
-3% -$248K ﹤0.01% 2148
2022
Q4 		$5.77M Sell
317,265
-33,425
-10% -$690K ﹤0.01% 2260
2022
Q3 		$7.98M Buy
350,690
+15,206
+5% +$325K ﹤0.01% 2033
2022
Q2 		$4.63M Buy
335,484
+53,459
+19% +$784K ﹤0.01% 2353
2022
Q1 		$6.41M Sell
282,025
-13,005
-4% -$342K ﹤0.01% 2290
2021
Q4 		$11M Sell
295,030
-20,946
-7% -$899K ﹤0.01% 2053
2021
Q3 		$13.4M Buy
315,976
+207,476
+191% +$9.99M ﹤0.01% 1960
2021
Q2 		$4.83M Buy
108,500
+4,425
+4% +$156K ﹤0.01% 2509
2021
Q1 		$3.75M Buy
104,075
+35,221
+51% +$1.39M ﹤0.01% 2586
2020
Q4 		$2.75M Buy
68,854
+23,475
+52% +$800K ﹤0.01% 2660
2020
Q3 		$1.31M Sell
45,379
-43,415
-49% -$938K ﹤0.01% 2951
2020
Q2 		$1.45M Sell
88,794
-417
-0.5% -$5.75K ﹤0.01% 2877
2020
Q1 		$848K Sell
89,211
-1,465
-2% -$20.1K ﹤0.01% 3088
2019
Q4 		$1.47M Buy
90,676
+12,198
+16% +$198K ﹤0.01% 3022
2019
Q3 		$1.3M Buy
78,478
+973
+1% +$18.3K ﹤0.01% 3007
2019
Q2 		$1.31M Buy
77,505
+13,336
+21% +$233K ﹤0.01% 3048
2019
Q1 		$1.15M Sell
64,169
-761
-1% -$12.1K ﹤0.01% 3080
2018
Q4 		$781K Buy
64,930
+17,209
+36% +$206K ﹤0.01% 3244
2018
Q3 		$835K Buy
+47,721
New +$944K ﹤0.01% 3371

Other funds holding BLFS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.36B AUM 17.81% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return

Bank of New York Mellon's BLFS Position: Q2 2026 in Review

Bank of New York Mellon increased its BioLife Solutions (BLFS) stake by 8.4% in Q2 2026, buying an estimated $416K and bringing the position to 229,109 shares worth $6.47M. The position accounts for ﹤0.01% of the portfolio, ranked #2286.

Bank of New York Mellon first reported a position in BLFS in Q3 2018 and has held it in 32 quarters since. The position peaked at $13.4M in Q3 2021. 82 funds tracked by Wall St. Rank hold BLFS as of Q2 2026.

  • Bank of New York Mellon held 229,109 shares of BioLife Solutions worth $6.47M as of Q2 2026.
  • Bank of New York Mellon bought 17,799 BioLife Solutions shares in Q2 2026, an estimated $416K.
  • BioLife Solutions made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #2286 holding.
  • Bank of New York Mellon first reported a position in BioLife Solutions in Q3 2018 and has held it in 32 quarters since.
  • Bank of New York Mellon's BioLife Solutions position peaked at $13.4M in Q3 2021.
  • 82 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.